Nobilus Ent
PolandAll drugs from this manufacturer
-
The medicinal product is used topically to support the treatment of bruises, sprains, inflammatory conditions with or without swelling, inflammation of the veins in the lower limbs, hematomas, and edema following injuries or surgical procedures. It also helps with spinal pain involving nerve root compression and relieves pain, heaviness in the legs, skin itching, and calf cramps.
Dosage form: gel
Active substance Dosage escinum 20 mg/g diethylamine salicylate 50 mg/g sodium heparin 50 j.m./g ATC: C05BA53
-
The medicine is used for excessively sweating areas, such as feet, armpits, and hands. It helps to reduce sweat gland activity and relieves discomfort associated with excessive sweating.
Dosage form: solution for skin
Active substance Dosage aluminum chloride 100 mg/1 g ATC: D03AX
-
The medicine is used to treat adults and children with acute lymphoblastic leukemia (Philadelphia chromosome-positive), certain myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome or chronic eosinophilic leukemia, as well as for the treatment of dermatofibrosarcoma protuberans.
Dosage form: capsules, hard
Active substance Dosage imatinib 100 mg ATC: L01XE01
-
The medicine is used in adults and children for the treatment of acute lymphoblastic leukemia (with the Philadelphia chromosome), certain myelodysplastic/myeloproliferative syndromes, hypereosinophilic syndrome, chronic eosinophilic leukemia, and dermatofibrosarcoma protuberans.
Dosage form: capsules, hard
Active substance Dosage imatinib 400 mg ATC: L01XE01
-
The medicine is used in adults, children, and adolescents for the treatment of, among others, chronic myeloid leukemia (CML), acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), and dermatofibrosarcoma protuberans (DFSP).
Dosage form: capsules, hard
Active substance Dosage imatinib 100 mg ATC: L01EA01
-
The medicine is used in adults, children, and adolescents for the treatment of, among others, chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), myelodysplastic/myeloproliferative syndromes (MDS/MPD), hypereosinophilic syndrome (HES) or chronic eosinophilic leukemia (CEL), as well as dermatofibrosarcoma protuberans (DFSP).
Dosage form: capsules, hard
Active substance Dosage imatinib 400 mg ATC: L01EA01